Skin Immune Response: SYX-5219 Treatment

We are investigating how SYX-5219 affects immune responses in the skin. This study aims to understand its potential benefits for skin-related conditions.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre for Human Drug Research
Dermatology
Oegstgeest, Netherlands
Sponsor: Sitryx Therapeutics Limited
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.